Antengene unveils three pipeline programs at AACR 2026 as AnTenGager platform expands beyond UCB deal
Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
Read More Pharma Industry News Novartis’ Sandoz gains EC approval for biosimilar Hyrimoz across multiple therapeutic areas In a significant advancement for biopharmaceuticals, Novartis’ division Sandoz has secured approval from the European Commission (EC) for… bypharmanewsdailyJuly 29, 2018
